Last Updated : December 2, 2010
Details
FilesGeneric Name:
Aztreonam for inhalation solution
Project Status:
Complete
Therapeutic Area:
Cystic fibrosis, chronic pulmonary pseudomonas aeruginosa infections
Manufacturer:
Gilead Sciences Canada Inc.
Call for patient/clinician input open:
Brand Name:
Cayston
Project Line:
Reimbursement Review
Project Number:
SR0220-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Cystic fibrosis (CF) with chronic pulmonary pseudomonas aeruginosa infections
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : December 2, 2010